Scarica l'app Stockscreener
21.44
2.14%
0.45
Dopo l'orario di chiusura:
21.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$20.99
Aprire:
$21.31
Volume 24 ore:
4.20M
Relative Volume:
1.07
Capitalizzazione di mercato:
$3.85B
Reddito:
$644.86M
Utile/perdita netta:
$196.05M
Rapporto P/E:
21.85
EPS:
0.9812
Flusso di cassa netto:
$317.50M
1 W Prestazione:
+1.56%
1M Prestazione:
+2.68%
6M Prestazione:
-44.64%
1 anno Prestazione:
-64.85%
Intervallo 1D:
$20.78
$21.60
Intervallo di 1 settimana:
$20.07
$21.60
Portata 52W:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, HQY, TEM, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
21.44 | 3.77B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
201.20 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.46 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
101.24 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.90 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
47.05 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Downgrade | Truist | Buy → Hold |
| 2026-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
DOCS|Doximity Inc|Price:20.974|Chg%:+0.553 - TradingKey
Doximity (DOCS) Laps the Stock Market: Here's Why - Yahoo Finance
Renaissance Technologies LLC Has $71.29 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Bank of Nova Scotia Takes Position in Doximity, Inc. $DOCS - MarketBeat
DOCS|Doximity Inc|Price:21.170|Chg%:+0.180 - TradingKey
Caxton Associates LLP Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Doximity Inc (DOCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Doximity Inc (DOCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Doximity Inc (DOCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Doximity, Inc. Revenue Breakdown – NYSE:DOCS - TradingView
Form 4 Doximity Inc For: 24 July By Investing.com - Investing.com Nigeria
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity Inc (DOCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Doximity, Inc. (DOCS) Options Chain - Yahoo! Finance Canada
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance Australia
Doximity, Inc. (DOCS) Latest Stock News & Headlines - Yahoo! Finance Canada
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
2 Reasons to Like DOCS (and 1 Not So Much) - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $22 - Moomoo
Doximity Chief Accounting Officer Sitaram Siddharth disposes of 1,732 shares worth $38,150.64 - Bitget
Sparta 24 Ltd. Takes $2.94 Million Position in Doximity, Inc. $DOCS - MarketBeat
How Doximity Inc. Class A (DOCS) Affects Rotational Strategy Timing - Stock Traders Daily
A Look at Doximity Inc (DOCS) After 3.1% Decline -- GF Value $49 - GuruFocus
Zoom, AppLovin, and Doximity Shares Are Falling, What You Need To Know - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - Yahoo Finance
Reasons to Retain Doximity Stock in Your Portfolio for Now - Yahoo Finance
Is AI ready to take over your prescriptions? Doctors are wary of Utah's automated refill program - AOL.com
Is Doximity (DOCS) Cheap As Its Clinical AI Tool Tops Safety Benchmark? - Sahm
AI has taken over prescription refills in Utah. Some doctors are wary - AOL.com
Medical watchdog reveals issues with recent medical student reports - AOL.com
Press Release: Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026 - Moomoo
Doximity to report fiscal Q1 2027 results on August 6 - scanx.trade
Doximity Sets Aug. 6 Webcast to Discuss Its June Quarter - Stock Titan
Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026 - Yahoo Finance
Doximity, Inc. ($DOCS) CEO 2026 Pay Revealed - Quiver Quantitative
DOCS (NYSE: DOCS) files Form 144 for 1,732-share sale - Stock Titan
Doximity (NYSE:DOCS) Attracts Renewed Market Interest - Kalkine Media
Doximity Outranks OpenEvidence, Frontier Models in Independent S - GuruFocus
11,000 Physician Experts Helped Improve Doximity's Clinical AI - Stock Titan
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety - Mid Florida Newspapers
Form DEF 14A Doximity For: 15 July By Investing.com - Investing.com Nigeria
Doximity | DEF 14A: Definitive information statements - Moomoo
Doximity (NYSE: DOCS) sets 2026 virtual meeting, pay and auditor votes - Stock Titan
Doximity (NYSE:DOCS) Upgraded at Zacks Research - MarketBeat
Doximity, Inc. SEC Filing (Jul 15, 2026) - Stock Titan
Form 4 Doximity Inc For: 14 July By Investing.com - Investing.com Nigeria
Doximity (DOCS) director receives 9,750 RSUs as committee voids part of prior grant - Stock Titan
Equity grant: Doximity (NYSE: DOCS) gives 21,314 RSUs to director - Stock Titan
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):